Craft

Advanced
Iconovo

Iconovo

Stock Price

KR5.4

2024-10-29

Market Capitalization

KR86 M

2024-10-29

Revenue

KR7.1 M

FY, 2023

Iconovo Summary

Company Summary

Overview
Iconovo is a company that offers the development of inhalation products: inhaler devices and dry powder formulations. It also assists in clinical trials and registration and develops proprietary generic drugs.
Type
Public
Status
Active
Founded
2013
HQ
Lund, SE | view all locations
Website
https://iconovo.se/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Vesna Åkerberg

    Vesna Åkerberg, Director Pharm. Development

    • Orest Lastow

      Orest Lastow, Director

      • Nina Bladh

        Nina Bladh, Director Project Management

        • Berndt Axelsson

          Berndt Axelsson, Director

          LocationsView all

          1 location detected

          • Lund, Skåne län HQ

            Sweden

            Scheeletorget 1

          Iconovo Financials

          Summary Financials

          Gross profit (Q3, 2024)
          (kr1.3M)
          Net income (Q3, 2024)
          (kr11.1M)
          Cash (Q3, 2024)
          kr8.9M
          EBIT (Q3, 2024)
          (kr11.1M)
          Enterprise value
          $85.0M

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2025
          Share price data provided by IEX